National Healthcare Properties, Inc. (NHPAP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
National Healthcare Properties, Inc. (NHPAP) stock price & volume — 10-year historical chart
National Healthcare Properties, Inc. (NHPAP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
National Healthcare Properties, Inc. (NHPAP) EPS & revenue vs analyst estimates — last 3 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Dec 31, 2025 | $0.80 | $84Mvs $98M-13.5% |
| Q4 2025 | Nov 5, 2025 | $0.44 | $86M |
| Q3 2025 | Aug 5, 2025 | $0.74 | $85M |
National Healthcare Properties, Inc. (NHPAP) competitors in Non-Industrial Diversified REITs — business model, growth, and fundamentals comparison
National Healthcare Properties, Inc. (NHPAP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
National Healthcare Properties, Inc. (NHPAP) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 302.39M | 311M | 362.41M | 374.91M | 381.61M | 329.36M | 335.85M | 345.93M | 353.79M | 348.45M |
| Revenue Growth % | 22.28% | 2.85% | 16.53% | 3.45% | 1.79% | -13.69% | 1.97% | 3% | 2.27% | -0.32% |
| Property Operating Expenses | 291.37M | 286M | 221M | 234.19M | 243.55M | 205.81M | 213.44M | 217.79M | 221.15M | 222.39M |
| Net Operating Income (NOI) | 11.02M▲ 0% | 25M▲ 126.8% | 141.41M▲ 465.7% | 140.73M▼ 0.5% | 138.06M▼ 1.9% | 123.54M▼ 10.5% | 122.4M▼ 0.9% | 128.13M▲ 4.7% | 132.65M▲ 3.5% | 126.07M▲ 0% |
| NOI Margin % | 3.64% | 8.04% | 39.02% | 37.54% | 36.18% | 37.51% | 36.45% | 37.04% | 37.49% | 36.18% |
| Operating Expenses | 0 | 0 | 144.59M | 172.52M | 157.94M | 160.98M | 153.94M | 132.87M | 256.19M | 140.54M |
| G&A Expenses | 0 | 0 | 17.27M | 20.53M | 21.57M | 16.83M | 17.29M | 18.93M | 22.74M | 21.93M |
| EBITDA | 94.67M | 83.78M | 80.04M | 49.24M | 61.1M | 42.29M | 50.52M | 78.14M | -39.47M | 71.5M |
| EBITDA Margin % | 31.31% | 26.94% | 22.08% | 13.13% | 16.01% | 12.84% | 15.04% | 22.59% | -11.16% | 20.52% |
| Depreciation & Amortization | 98.89M | 77.64M | 83.21M | 81.03M | 80.97M | 79.73M | 82.06M | 82.87M | 84.07M | 85.98M |
| D&A / Revenue % | 32.7% | 24.96% | 22.96% | 21.61% | 21.22% | 24.21% | 24.44% | 23.96% | 23.76% | 24.67% |
| Operating Income | -4.22M▲ 0% | 6.14M▲ 245.6% | -3.18M▼ 151.7% | -31.79M▼ 900.9% | -19.87M▲ 37.5% | -37.44M▼ 88.4% | -31.54M▲ 15.7% | -4.74M▲ 85.0% | -123.54M▼ 2507.5% | -14.47M▲ 0% |
| Operating Margin % | -1.39% | 1.97% | -0.88% | -8.48% | -5.21% | -11.37% | -9.39% | -1.37% | -34.92% | -4.15% |
| Interest Expense | 0 | 0 | 49.47M | 56.06M | 51.52M | 47.9M | 51.74M | 66.08M | 69.45M | 4M |
| Interest Coverage | - | - | -0.06x | -0.57x | -0.39x | -0.78x | -0.61x | -0.07x | -1.78x | - |
| Non-Operating Income | 0 | 0 | 134K | 61K | 58K | -98K | -3.86M | 1.26M | -23.52M | -144K |
| Pretax Income | -23.05M▲ 0% | -42.06M▼ 82.5% | -52.78M▼ 25.5% | -87.91M▼ 66.6% | -71.45M▲ 18.7% | -85.24M▼ 19.3% | -79.42M▲ 6.8% | -72.08M▲ 9.2% | -190M▼ 163.6% | -80.02M▲ 0% |
| Pretax Margin % | -7.62% | -13.53% | -14.56% | -23.45% | -18.72% | -25.88% | -23.65% | -20.84% | -53.7% | -22.97% |
| Income Tax | -2.08M | 647K | 197K | 399K | 4.06M | 203K | 201K | 303K | 262K | 121K |
| Effective Tax Rate % | 9.04% | -1.54% | -0.37% | -0.45% | -5.68% | -0.24% | -0.25% | -0.42% | -0.14% | -0.15% |
| Net Income | -20.87M▲ 0% | -42.55M▼ 103.8% | -52.76M▼ 24.0% | -87.91M▼ 66.6% | -75.81M▲ 13.8% | -85.18M▼ 12.4% | -79.49M▲ 6.7% | -72.3M▲ 9.0% | -189.7M▼ 162.4% | -80.05M▲ 0% |
| Net Margin % | -6.9% | -13.68% | -14.56% | -23.45% | -19.87% | -25.86% | -23.67% | -20.9% | -53.62% | -22.97% |
| Net Income Growth % | 49.99% | -103.83% | -24.01% | -66.62% | 13.76% | -12.36% | 6.68% | 9.04% | -162.38% | 53.71% |
| Funds From Operations (FFO) | 78.01M▲ 0% | 35.09M▼ 55.0% | 30.45M▼ 13.2% | -6.89M▼ 122.6% | 5.16M▲ 174.9% | -5.45M▼ 205.7% | 2.58M▲ 147.3% | 10.57M▲ 310.2% | -105.63M▼ 1098.9% | 5.92M▲ 0% |
| FFO Margin % | 25.8% | 11.28% | 8.4% | -1.84% | 1.35% | -1.66% | 0.77% | 3.06% | -29.86% | 1.7% |
| FFO Growth % | 209.54% | -55.02% | -13.23% | -122.61% | 174.93% | -205.66% | 147.29% | 310.2% | -1098.86% | 147.68% |
| FFO per Share | 2.95 | 1.30 | 1.10 | - | 0.18 | -0.19 | 0.09 | 0.37 | -3.73 | 0.21 |
| FFO Payout Ratio % | 96.69% | 218.61% | 181.7% | -746.83% | 607.64% | 0% | 535.26% | 130.5% | 0% | 0% |
| EPS (Diluted) | -0.79▲ 0% | -1.57▼ 98.7% | -1.90▼ 21.2% | 0.00▲ 100.0% | -2.79▲ 0% | -3.29▼ 17.9% | -3.30▼ 0.3% | -3.04▲ 7.9% | -7.19▼ 136.5% | -2.83▲ 0% |
| EPS Growth % | 51.23% | -98.73% | -21.23% | 100% | - | -17.92% | -0.3% | 7.88% | -136.51% | - |
| EPS (Basic) | -0.79 | -1.57 | -1.90 | 0.00 | -2.79 | -3.29 | -3.30 | -3.04 | -7.19 | - |
| Diluted Shares Outstanding | 26.48M | 27.06M | 27.72M | 0 | 28.29M | 28.29M | 28.29M | 28.29M | 28.29M | 28.3M |
National Healthcare Properties, Inc. (NHPAP) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.19B | 2.37B | 2.38B | 2.33B | 2.29B | 2.21B | 2.18B | 2.15B | 1.95B | 1.76B |
| Asset Growth % | -3.45% | 8.12% | 0.24% | -2.19% | -1.65% | -3.17% | -1.54% | -1.61% | -9.28% | -48.24% |
| Real Estate & Other Assets | 0 | 0 | 0 | 1.84B | 1.88B | 1.81B | 1.78B | 1.73B | 1.79B | 1.37B |
| PP&E (Net) | 0 | 0 | 0 | 14.35M | 13.91M | 7.91M | 7.81M | 7.71M | 7.48M | 6.84M |
| Investment Securities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 0 | 0 | 0 | 203.62M | 113.76M | 109.24M | 101.81M | 117.64M | 96.94M | 134.52M |
| Cash & Equivalents | 33.19M | 102.59M | 91.36M | 95.69M | 72.36M | 59.74M | 53.65M | 46.41M | 21.65M | 47.12M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | -45.21M | -117.92M | -108.71M | 47.04M | -16.85M | -6.92M | -11.67M | 44.91M | 52.44M | 57.77M |
| Intangible Assets | 0 | 0 | 0 | 21.18M | 23.32M | 23.86M | 25.28M | 26.32M | 55.37M | 29.63M |
| Total Liabilities | 689.38M | 1.02B | 1.14B | 1.22B | 1.33B | 1.17B | 1.18B | 1.24B | 1.26B | 1.11B |
| Total Debt | 644.44M | 960.33M | 1.08B | 1.14B | 1.23B | 1.09B | 1.12B | 1.18B | 1.15B | 1.04B |
| Net Debt | 611.25M | 857.74M | 991.21M | 1.05B | 1.15B | 1.03B | 1.06B | 1.13B | 1.13B | 994.81M |
| Long-Term Debt | 589.42M | 857.97M | 1.03B | 528.28M | 542.7M | 584.24M | 578.7M | 809M | 1.14B | 696.51M |
| Short-Term Borrowings | 34.83M | 83.53M | 38.35M | 605.27M | 674.55M | 502.05M | 530.3M | 361.03M | 362.22M | 337.62M |
| Capital Lease Obligations | 0 | 0 | 0 | 9.13M | 9.15M | 8.13M | 8.09M | 8.04M | 8.11M | 38.76M |
| Total Current Liabilities | 0 | 0 | 0 | 663.78M | 724.48M | 556.78M | 584.97M | 419.38M | 462.5M | 396.73M |
| Accounts Payable | 0 | 0 | 0 | 43.09M | 42.27M | 42.71M | 45.25M | 48.36M | 89.58M | 46.32M |
| Deferred Revenue | 4.99M | 6.2M | 7.01M | 8.52M | 6.91M | 8.62M | 5.92M | 6.5M | 7.22M | 9.35M |
| Other Liabilities | -614.6M | -883M | -1.05B | 8.84M | 42.28M | 24.85M | 9.41M | 8.16M | 6.13M | 5.38M |
| Total Equity | 1.5B▲ 0% | 1.36B▼ 9.9% | 1.24B▼ 8.5% | 1.11B▼ 10.8% | 961.37M▼ 13.1% | 1.04B▲ 8.2% | 999.19M▼ 4.0% | 900.58M▼ 9.9% | 690.13M▼ 23.4% | 652.48M▲ 0% |
| Equity Growth % | -6.09% | -9.86% | -8.49% | -10.81% | -13.14% | 8.22% | -3.96% | -9.87% | -23.37% | -85.57% |
| Shareholders Equity | 1.5B | 1.35B | 1.23B | 1.1B | 956.99M | 1.03B | 992.64M | 894.15M | 684.56M | 647.03M |
| Minority Interest | 8.87M | 8.51M | 7.8M | 5.41M | 4.39M | 6.7M | 6.55M | 6.43M | 5.57M | 5.45M |
| Common Stock | 894K | 910K | 919K | 923K | 938K | 993K | 1.05M | 1.11M | 1.13M | 1.13M |
| Additional Paid-in Capital | 1.98B | 2.01B | 2.03B | 2.08B | 2.1B | 2.33B | 2.42B | 2.51B | 2.53B | 2.53B |
| Retained Earnings | -486.57M | -665.03M | -804.33M | -971.19M | -1.11B | -1.28B | -1.46B | -1.64B | -1.87B | -1.9B |
| Preferred Stock | 0 | 0 | 0 | 16K | 16K | 76K | 76K | 76K | 76K | 75K |
| Return on Assets (ROA) | -0.93% | -1.86% | -2.22% | -3.74% | -3.29% | -3.78% | -3.62% | -3.34% | -9.27% | -4.55% |
| Return on Equity (ROE) | -1.34% | -2.97% | -4.06% | -7.49% | -7.33% | -8.51% | -7.79% | -7.61% | -23.85% | -12.27% |
| Debt / Assets | 29.38% | 40.49% | 45.53% | 49.14% | 53.63% | 49.42% | 51.23% | 54.92% | 59.07% | 59.24% |
| Debt / Equity | 0.43x | 0.71x | 0.87x | 1.03x | 1.28x | 1.05x | 1.12x | 1.31x | 1.67x | 1.67x |
| Net Debt / EBITDA | 6.46x | 10.24x | 12.38x | 21.26x | 18.89x | 24.46x | 21.05x | 14.48x | - | 13.91x |
| Book Value per Share | 56.82 | 50.12 | 44.77 | - | 33.99 | 36.78 | 35.32 | 31.84 | 24.40 | 23.06 |
National Healthcare Properties, Inc. (NHPAP) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 78.72M | 63.97M | 54.15M | 47.4M | 41.81M | 38.88M | 28.3M | 21.62M | -79.85M | -79.85M |
| Operating CF Growth % | 14.63% | -18.75% | -15.35% | -12.46% | -11.81% | -7% | -27.22% | -23.58% | -469.25% | -2662.65% |
| Operating CF / Revenue % | 26.03% | 20.57% | 14.94% | 12.64% | 10.96% | 11.8% | 8.42% | 6.25% | -22.57% | -22.91% |
| Net Income | -20.87M | -42.55M | -52.98M | -88.31M | -75.51M | -85.44M | -79.62M | -72.38M | -190.26M | -80.05M |
| Depreciation & Amortization | 98.89M | 77.64M | 83.21M | 81.03M | 80.97M | 79.73M | 81.44M | 81.98M | 82.64M | 83.9M |
| Stock-Based Compensation | 0 | 0 | 1.24M | 1.32M | 1.34M | 1.33M | 1.19M | 919K | 613K | 723K |
| Other Non-Cash Items | 17.21M | 36.3M | 44.05M | 62.72M | 38.99M | 43.69M | 32.72M | 16.4M | 24.21M | 24.69M |
| Working Capital Changes | -16.5M | -7.43M | -21.63M | -9.36M | -8.63M | 57K | -10.18M | -6.46M | 558K | -132.07M |
| Cash from Investing | -19.09M | -193.94M | -115.06M | -46.25M | -82.49M | -47.92M | -41.78M | -62.82M | 63.97M | 155.69M |
| Acquisitions (Net) | 0 | 1.34M | 0 | 0 | 0 | 0 | 0 | 284K | 0 | 0 |
| Purchase of Investments | -38.75M | -188.93M | -128.06M | -92M | -94.98M | -159.3M | -25.54M | -9.96M | -5.61M | 0 |
| Sale of Investments | 1000K | 757K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 3M |
| Other Investing | 100K | 1.18M | -102.15M | -29.53M | -60.6M | -28.85M | -13.79M | -9.96M | -1.71M | 4.8M |
| Cash from Financing | -55.57M | 199.37M | 49.68M | 19.09M | 19.43M | 4.08M | 4.64M | 55.97M | -1.35M | -31.54M |
| Dividends Paid | -75.43M | -76.72M | -55.33M | -51.43M | -33.75M | -5.14M | -13.8M | -13.8M | -13.8M | -13.73M |
| Common Dividends | 0 | 0 | -55.33M | -51.43M | -31.35M | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -2M |
| Share Repurchases | -12.18M | -33.6M | -14.2M | -21.11M | -10.54M | 0 | -42K | 0 | 0 | -1.74M |
| Other Financing | -761K | -857K | -3.98M | -22.02M | -3.12M | -1.62M | -1.86M | -8.65M | -184K | -191K |
| Net Change in Cash | 0▲ 0% | 0▲ 0% | -11.23M▲ 0% | 20.24M▲ 280.2% | -21.25M▼ 205.0% | -4.96M▲ 76.6% | -8.84M▼ 78.2% | 14.78M▲ 267.1% | -17.22M▼ 216.5% | 22.2M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 29.12M | 33.19M | 102.59M | 91.36M | 111.6M | 90.35M | 85.38M | 76.54M | 91.32M | 126.41M |
| Cash at End | 33.19M | 102.59M | 91.36M | 111.6M | 90.35M | 85.38M | 76.54M | 91.32M | 74.09M | 103.17M |
| Free Cash Flow | 71.25M▲ 0% | 55.69M▼ 21.8% | 41.24M▼ 25.9% | 30.68M▼ 25.6% | 19.91M▼ 35.1% | 19.81M▼ 0.5% | 302K▼ 98.5% | -773K▼ 356.0% | -101.75M▼ 13063.5% | -125.07M▲ 0% |
| FCF Growth % | 15.3% | -21.84% | -25.94% | -25.6% | -35.1% | -0.54% | -98.48% | -355.96% | -13063.52% | -2658.54% |
| FCF / Revenue % | 23.56% | 17.91% | 11.38% | 8.18% | 5.22% | 6.01% | 0.09% | -0.22% | -28.76% | -35.89% |
National Healthcare Properties, Inc. (NHPAP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 2.95 | 1.3 | 1.1 | - | 0.18 | -0.19 | 0.09 | 0.37 | -3.73 | 0.21 |
| FFO Payout Ratio | 96.69% | 218.61% | 181.7% | -746.83% | 607.64% | 0% | 535.26% | 130.5% | 0% | 0% |
| NOI Margin | 3.64% | 8.04% | 39.02% | 37.54% | 36.18% | 37.51% | 36.45% | 37.04% | 37.49% | 36.18% |
| Net Debt / EBITDA | 6.46x | 10.24x | 12.38x | 21.26x | 18.89x | 24.46x | 21.05x | 14.48x | - | 13.91x |
| Debt / Assets | 29.38% | 40.49% | 45.53% | 49.14% | 53.63% | 49.42% | 51.23% | 54.92% | 59.07% | 59.24% |
| Interest Coverage | - | - | -0.06x | -0.57x | -0.39x | -0.78x | -0.61x | -0.07x | -1.78x | - |
| Book Value / Share | 56.82 | 50.12 | 44.77 | - | 33.99 | 36.78 | 35.32 | 31.84 | 24.4 | 23.06 |
| Revenue Growth | 22.28% | 2.85% | 16.53% | 3.45% | 1.79% | -13.69% | 1.97% | 3% | 2.27% | -0.32% |
National Healthcare Properties, Inc. (NHPAP) stock FAQ — growth, dividends, profitability & financials explained
National Healthcare Properties, Inc. (NHPAP) reported $348.5M in revenue for fiscal year 2024. This represents a 496% increase from $58.4M in 2014.
National Healthcare Properties, Inc. (NHPAP) grew revenue by 2.3% over the past year. Growth has been modest.
National Healthcare Properties, Inc. (NHPAP) reported a net loss of $80.1M for fiscal year 2024.
Yes, National Healthcare Properties, Inc. (NHPAP) pays a dividend with a yield of 2.29%. This makes it attractive for income-focused investors.
National Healthcare Properties, Inc. (NHPAP) has a return on equity (ROE) of -23.9%. Negative ROE indicates the company is unprofitable.
National Healthcare Properties, Inc. (NHPAP) generated Funds From Operations (FFO) of $5.9M in the trailing twelve months. FFO is the primary profitability metric for REITs.
National Healthcare Properties, Inc. (NHPAP) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates